ABVC BioPharma
ABVC
ABVC BioPharma (ABVC) news
Recent news
ImportantABVC Biopharma rockets 99% premarket after receiving $460M from Aibtl Biopharma as the first milestone payment of global licensing fees
AInvest Wire · Jan 3, 2024ABVC BioPharma and its subsidiary receive $460M from Aibtl BioPharma as the first milestone payment of global licensing fees
ABVC BioPharma and its subsidiary receive $460M from Aibtl BioPharma as the first milestone payment of global licensing fees ABVC BioPharma and its subsidiary, BioLite, have recently received a significant milestone payment of $460 million from AiBtl BioPharma. This payment is the first of…
AInvest Wire · Jan 3, 2024ImportantABVC BioPharma Shares Rise 8% After U.S. Patent for ADHD Treatment
AInvest Wire · Nov 21, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.